Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 08:40 am Purchase | 13G | EDITAS MEDICINE INC EDIT | Deep Track Capital LP | 5,473,086 6.7% | 979,670 (+21.80%) | View |
| 2024-02-14 08:39 am Sale | 13G | DYNE THERAPEUTICS INC DYN | Deep Track Capital LP | 2,000,000 3.26% | -2,500,000 (-55.56%) | View |
| 2024-02-14 08:39 am Purchase | 13G | DYNAVAX TECHNOLOGIES CORP COM DVAX | Deep Track Capital LP | 7,093,214 5.49% | 537,034 (+8.19%) | View |
| 2024-02-14 08:37 am Purchase | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Deep Track Capital LP | 3,490,506 9.25% | 671,461 (+23.82%) | View |
| 2024-02-14 08:37 am Sale | 13G | AUTOLUS THERAPEUTICS PLC SPONS AUTL | Deep Track Capital LP | 11,869,297 6.82% | -3,130,703 (-20.87%) | View |
| 2024-02-14 08:36 am Sale | 13G | ASTRIA THERAPEUTICS INC ATXS | Deep Track Capital LP | 0 0% | -1,816,531 (Position Closed) | View |
| 2024-02-14 08:35 am Sale | 13G | APOGEE THERAPEUTICS INC APGE | Deep Track Capital LP | 2,323,456 6.25% | -700,000 (-23.15%) | View |
| 2024-02-14 08:35 am Purchase | 13G | ANAPTYSBIO INC ANAB | Deep Track Capital LP | 2,036,990 7.67% | 676,814 (+49.76%) | View |
| 2024-02-14 08:34 am Sale | 13G | ALLAKOS INC ALLK | Deep Track Capital LP | 2,510,736 2.87% | -2,489,264 (-49.79%) | View |
| 2024-02-14 08:33 am Sale | 13G | ALBIREO PHARMA INC ALBO | Deep Track Capital LP | 0 0% | -1,704,000 (Position Closed) | View |
| 2024-02-14 08:33 am Purchase | 13G | AGENUS INC AGEN | Deep Track Capital LP | 31,697,539 8.31% | 4,697,539 (+17.40%) | View |
| 2024-02-14 08:32 am Sale | 13G | ACUMEN PHARMACEUTICALS INC ABOS | Deep Track Capital LP | 0 0% | -3,952,000 (Position Closed) | View |
| 2024-02-12 4:01 pm Purchase | 13G | INVIVYD, INC. IVVD | Deep Track Capital LP | 9,000,000 7.56% | 9,000,000 (New Position) | View |
| 2024-01-26 4:20 pm Purchase | 13G | ALLAKOS INC ALLK | Deep Track Capital LP | 5,000,000 5.72% | 2,489,264 (+99.14%) | View |
| 2024-01-26 09:21 am Sale | 13G | ALLAKOS INC ALLK | Deep Track Capital LP | 2,510,736 2.87% | -2,388,443 (-48.75%) | View |
| 2024-01-19 4:38 pm Purchase | 13G | DYNE THERAPEUTICS INC DYN | Deep Track Capital LP | 4,500,000 5.55% | 2,500,000 (+125.00%) | View |
| 2024-01-19 09:08 am Sale | 13G | DYNE THERAPEUTICS INC DYN | Deep Track Capital LP | 2,000,000 3.26% | -684,200 (-25.49%) | View |
| 2023-12-22 4:04 pm Purchase | 13G | OCULAR THERAPEUTIX INC OCUL | Deep Track Capital LP | 9,230,769 8.38% | 9,230,769 (New Position) | View |
| 2023-11-02 4:09 pm Purchase | 13G | AMBRX BIOPHARMA INC AMAM | Deep Track Capital LP | 3,710,412 5.65% | 3,710,412 (New Position) | View |
| 2023-11-02 4:08 pm Purchase | 13G | ALIGOS THERAPEUTICS INC ALGS | Deep Track Capital LP | 7,295,967 9.99% | 7,295,967 (New Position) | View |